{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T12:45:15Z","timestamp":1787661915404,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.peptides.2013.12.002","type":"journal-article","created":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T01:46:49Z","timestamp":1386553609000},"page":"49-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A P2 and P3 substrate specificity comparison between the Murray Valley encephalitis and West Nile virus NS2B\/NS3 protease using C-terminal agmatine dipeptides"],"prefix":"10.1016","volume":"52","author":[{"given":"Melgious Jin Yan","family":"Ang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhitao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huichang Annie","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fui Mee","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Wen","family":"Then","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Liang Kuan","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joma","family":"Joy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S. Brian","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2013.12.002_bib0005","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1016\/j.tetlet.2012.08.002","article-title":"Solid-phase synthesis of a library of C-terminal agmatine dipeptides using a backbone amide linker (BAL) strategy","volume":"53","author":"Ang","year":"2012","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.peptides.2013.12.002_bib0010","doi-asserted-by":"crossref","first-page":"12895","DOI":"10.1128\/JVI.00942-09","article-title":"Crystal structure of a novel conformational state of the flavivirus NS3 protein: implications for polyprotein processing and viral replication","volume":"83","author":"Assenberg","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.peptides.2013.12.002_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2013.04.015","article-title":"Resurgence of West Nile neurologic disease in the United States in 2012: what happened?","volume":"99","author":"Beasly","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.peptides.2013.12.002_bib0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.33321\/cdi.2002.26.8","article-title":"Reappearance of human cases due to Murray Valley encephalitis virus and Kunjin virus in Central Australia after an absence of 26 years","volume":"26","author":"Brown","year":"2002","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.peptides.2013.12.002_bib0025","doi-asserted-by":"crossref","first-page":"38448","DOI":"10.1074\/jbc.M607641200","article-title":"Insights to substrate binding and processing by West Nile virus NS3 protease through combined modeling, protease mutagenesis and kinetic studies","volume":"281","author":"Chappell","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2013.12.002_bib0030","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.2174\/092986708786242804","article-title":"West Nile virus NS2B\/NS3 protease as an antiviral target","volume":"281","author":"Chappell","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.peptides.2013.12.002_bib0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0022-2836(86)90435-3","article-title":"Partial nucleotide sequence of the Murray Valley encephalitis virus genome","volume":"187","author":"Dalgarno","year":"1986","journal-title":"J Mol Biol"},{"key":"10.1016\/j.peptides.2013.12.002_bib0040","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.antiviral.2009.05.006","article-title":"Progress on the development of therapeutics against West Nile virus","volume":"83","author":"Diamond","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.peptides.2013.12.002_bib0045","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5694\/j.1326-5377.1952.tb74985.x","article-title":"Murray Valley encephalitis: isolation and characterization of the aetiological agent","volume":"1","author":"French","year":"1952","journal-title":"Med J Aust"},{"key":"10.1016\/j.peptides.2013.12.002_bib0050","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.drudis.2008.04.001","article-title":"Present perspectives on flaviviral chemotherapy","volume":"13","author":"Ghosh","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.peptides.2013.12.002_bib0055","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/j.febslet.2010.05.062","article-title":"Biochemical characterization of the Murray Valley encephalitis virus proteinase","volume":"584","author":"Joy","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.peptides.2013.12.002_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5694\/mja11.11026","article-title":"Murray Valley encephalitis: a review of clinical features, diagnosis and treatment","volume":"196","author":"Knox","year":"2012","journal-title":"Med J Aust"},{"key":"10.1016\/j.peptides.2013.12.002_bib0065","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1016\/j.ejmech.2011.04.055","article-title":"Novel agmatine and agmatine-like peptidomimetic inhibitors of the West Nile virus NS2B\/NS3 serine protease","volume":"46","author":"Lim","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.peptides.2013.12.002_bib0070","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1099\/vir.0.82735-0","article-title":"Yellow Fever virus NS3 protease: peptide-inhibition studies","volume":"88","author":"L\u00f6hr","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.peptides.2013.12.002_bib0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0378-1135(95)00074-K","article-title":"Australian X disease, Murray Valley encephalitis and the French connection","volume":"46","author":"Mackenzie","year":"1995","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.peptides.2013.12.002_bib0080","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/nm1144","article-title":"Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and Dengue viruses","volume":"10","author":"Mackenzie","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.peptides.2013.12.002_bib0085","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nrd3214","article-title":"Excitement grows for potential revolution in hepatitis C virus treatment","volume":"9","author":"Opar","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.peptides.2013.12.002_bib0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the size of active sites in proteases. I. Papain","volume":"27","author":"Schechter","year":"1967","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.peptides.2013.12.002_bib0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1940.s1-20.471","article-title":"A neurotropic virus isolated from the blood of a native of Uganda","volume":"20","author":"Smithburn","year":"1940","journal-title":"Am J Trop Med"},{"key":"10.1016\/j.peptides.2013.12.002_bib0100","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.1021\/jm800503y","article-title":"Potent cationic inhibitors of West Nile virus NS2B\/NS3 protease with serum stability, cell permeability and antiviral activity","volume":"51","author":"Stoermer","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.peptides.2013.12.002_bib0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.tips.2012.03.012","article-title":"Discovery of Boceprevir, a direct-acting NS3\/4A protease inhibitor for treatment of chronic hepatitis C infections","volume":"33","author":"Venkatraman","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.peptides.2013.12.002_bib0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bmcl.2005.09.049","article-title":"Peptide inhibitors of the Dengue virus NS3 protease","volume":"16","author":"Yin","year":"2006","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019697811300404X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019697811300404X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:47:21Z","timestamp":1762264041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019697811300404X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":22,"alternative-id":["S019697811300404X"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2013.12.002","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A P2 and P3 substrate specificity comparison between the Murray Valley encephalitis and West Nile virus NS2B\/NS3 protease using C-terminal agmatine dipeptides","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2013.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}